Literature DB >> 12244103

Characterization of the Ikappa B-kinase NEMO binding domain.

Michael J May1, Ralf B Marienfeld, Sankar Ghosh.   

Abstract

Proinflammatory activation of NF-kappaB requires an upstream kinase complex (IkappaB-kinase; IKK) composed of two catalytic subunits (IKKalpha and IKKbeta) and a noncatalytic regulatory component named NEMO (NF-kappaB essential modulator). NEMO interacts with a COOH-terminal sequence within both IKKs termed the NEMO-binding domain (NBD), and a cell-permeable NBD peptide blocks NEMO/IKKbeta interactions and inhibits tumor necrosis factor-alpha-induced NF-kappaB. We report here that a peptide encompassing the NBD not only blocked association of both IKKs with NEMO but also disrupted preformed NEMO/IKK complexes in vitro. Furthermore, peptide blocking and alanine-scanning mutation studies revealed differences between the NBDs of IKKalpha and IKKbeta, and mutational analysis of the IKKbeta NBD identified the physical properties required at each position to maintain association with NEMO. Finally, we demonstrate that loss of NEMO-binding by IKKbeta through deletion of the NBD renders it catalytically active and that potential phosphorylation within the IKKbeta NBD may serve as a signal to down-regulate IKK activity. Our findings therefore provide critical insight into the physical properties of the NBD that will be valuable for the design of drugs aimed at disrupting the IKK complex and also reveal potential regulatory mechanisms controlling the function of the IKK complex.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12244103     DOI: 10.1074/jbc.M206494200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  64 in total

1.  Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-kappaB in the absence of NF-kappaB essential modifier residues 133-224 or 373-419.

Authors:  Daniela Boehm; Benjamin E Gewurz; Elliott Kieff; Ellen Cahir-McFarland
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-05       Impact factor: 11.205

2.  High-affinity interaction between IKKbeta and NEMO.

Authors:  Yu-Chih Lo; Upendra Maddineni; Jee Y Chung; Rebecca L Rich; David G Myszka; Hao Wu
Journal:  Biochemistry       Date:  2008-02-12       Impact factor: 3.162

3.  Inhibition of the classical NF-kappaB pathway prevents osteoclast bone-resorbing activity.

Authors:  Niroshani S Soysa; Neil Alles; Hitoyata Shimokawa; Eijiro Jimi; Kazuhiro Aoki; Keiichi Ohya
Journal:  J Bone Miner Metab       Date:  2009-01-27       Impact factor: 2.626

4.  NF-κB inhibitor targeted to activated endothelium demonstrates a critical role of endothelial NF-κB in immune-mediated diseases.

Authors:  Bettina Sehnert; Harald Burkhardt; Johannes T Wessels; Agnes Schröder; Michael J May; Dietmar Vestweber; Jochen Zwerina; Klaus Warnatz; Falk Nimmerjahn; Georg Schett; Stefan Dübel; Reinhard Edmund Voll
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-23       Impact factor: 11.205

Review 5.  A structural guide to proteins of the NF-kappaB signaling module.

Authors:  Tom Huxford; Gourisankar Ghosh
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-09       Impact factor: 10.005

Review 6.  The NF-kappaB family of transcription factors and its regulation.

Authors:  Andrea Oeckinghaus; Sankar Ghosh
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10       Impact factor: 10.005

7.  Regulation of I(kappa)B kinase complex by phosphorylation of (gamma)-binding domain of I(kappa)B kinase (beta) by Polo-like kinase 1.

Authors:  Tomoyasu Higashimoto; Nymph Chan; Yung-Kang Lee; Ebrahim Zandi
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

Review 8.  Cell penetrating peptide inhibitors of nuclear factor-kappa B.

Authors:  J S Orange; M J May
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

9.  The inhibitor ABIN-2 disrupts the interaction of receptor-interacting protein with the kinase subunit IKKgamma to block activation of the transcription factor NF-kappaB and potentiate apoptosis.

Authors:  Wei-Kuang Liu; Pei-Fen Yen; Chia-Yi Chien; Ming-Ji Fann; Jin-Yuan Su; Chen-Kung Chou
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

10.  Impediment of NEMO oligomerization inhibits osteoclastogenesis and osteolysis.

Authors:  Isra Darwech; Jesse Otero; Muhammad Alhawagri; Simon Dai; Yousef Abu-Amer
Journal:  J Cell Biochem       Date:  2009-12-15       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.